141 related articles for article (PubMed ID: 22886094)
1. Autoimmune retinopathy associated with colonic adenoma.
Saito W; Kase S; Ohguro H; Ishida S
Graefes Arch Clin Exp Ophthalmol; 2013 May; 251(5):1447-9. PubMed ID: 22886094
[No Abstract] [Full Text] [Related]
2. Recoverin-associated retinopathy secondary to Warthin tumor of parotid gland.
Machida S; Ohguro H; Ishida K; Suzuki M; Kawagishi K
Doc Ophthalmol; 2014 Oct; 129(2):123-8. PubMed ID: 25149652
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal Dexamethasone Implant with Plasma Autoantibody Monitoring for Cancer-associated Retinopathy.
Kim MS; Hong HK; Park KH; Woo SJ
Korean J Ophthalmol; 2019 Jun; 33(3):298-300. PubMed ID: 31179664
[No Abstract] [Full Text] [Related]
4. Non-paraneoplastic autoimmune retinopathy that developed in fellow eye 10 years after onset in first eye: a case report.
Miura G; Baba T; Iwase T; Ohde H; Kanda A; Saito W; Ishida S; Yamamoto S
BMC Ophthalmol; 2020 Apr; 20(1):132. PubMed ID: 32252709
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies to transient receptor potential cation channel, subfamily M, member 1 in a Japanese patient with melanoma-associated retinopathy.
Morita Y; Kimura K; Fujitsu Y; Enomoto A; Ueno S; Kondo M; Sonoda KH
Jpn J Ophthalmol; 2014 Mar; 58(2):166-71. PubMed ID: 24468869
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune retinopathy with positive anti-recoverin antibodies not associated with neoplasms: Case report.
Oporto Caroca JI; Oporto Caroca J
Arch Soc Esp Oftalmol (Engl Ed); 2019 Nov; 94(11):540-544. PubMed ID: 31470998
[TBL] [Abstract][Full Text] [Related]
7. Cystoid macular edema from cancer-associated retinopathy.
Moyer K; DeWilde A; Law C
Optom Vis Sci; 2014 Apr; 91(4 Suppl 1):S66-70. PubMed ID: 24531653
[TBL] [Abstract][Full Text] [Related]
8. Intravenous rituximab for the treatment of cancer-associated retinopathy.
Or C; Collins DR; Merkur AB; Wang Y; Chan CC; Forooghian F
Can J Ophthalmol; 2013 Apr; 48(2):e35-8. PubMed ID: 23561621
[No Abstract] [Full Text] [Related]
9. A case of melanoma-associated retinopathy with autoantibodies against TRPM1.
Kim MS; Hong HK; Ko YJ; Park KH; Ueno S; Okado S; Woo SJ; Joo K
Doc Ophthalmol; 2020 Dec; 141(3):313-318. PubMed ID: 32472235
[TBL] [Abstract][Full Text] [Related]
10. Carcinoma-associated retinopathy in a young teenager with immature teratoma of the ovary.
Turaka K; Kietz D; Krishnamurti L; Mitchell E; Scanga H; Fu VL; Sylvester C
J AAPOS; 2014 Aug; 18(4):396-8. PubMed ID: 25173906
[TBL] [Abstract][Full Text] [Related]
11. Unilateral manifestation of autoimmune retinopathy.
Almeida DR; Chin EK; Niles P; Kardon R; Sohn EH
Can J Ophthalmol; 2014 Aug; 49(4):e85-7. PubMed ID: 25103665
[No Abstract] [Full Text] [Related]
12. Rituximab treatment for nonparaneoplastic autoimmune retinopathy.
Fox A; Jeffrey B; Hasni S; Nussenblatt R; Sen HN
Can J Ophthalmol; 2015 Dec; 50(6):e101-4. PubMed ID: 26651312
[No Abstract] [Full Text] [Related]
13. Bilateral paraneoplastic optic neuropathy and unilateral retinal compromise in association with prostate cancer: a differential diagnostic challenge in a patient with unexplained visual loss.
Carboni G; Forma G; Bond AD; Adamus G; Iannaccone A
Doc Ophthalmol; 2012 Aug; 125(1):63-70. PubMed ID: 22569848
[TBL] [Abstract][Full Text] [Related]
14. Outcomes Associated With Sustained-Release Intraocular Fluocinolone Implants in a Case of Melanoma-Associated Retinopathy Treated Without Systemic Immunosuppression.
Karatsai E; Robson AG; Taylor SRJ
JAMA Ophthalmol; 2019 May; 137(5):564-567. PubMed ID: 30896772
[TBL] [Abstract][Full Text] [Related]
15. A case of paraneoplastic optic neuropathy and outer retinitis positive for autoantibodies against collapsin response mediator protein-5, recoverin, and α-enolase.
Saito M; Saito W; Kanda A; Ohguro H; Ishida S
BMC Ophthalmol; 2014 Jan; 14():5. PubMed ID: 24428923
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune retinopathy and antiretinal antibodies: a review.
Grewal DS; Fishman GA; Jampol LM
Retina; 2014 May; 34(5):827-45. PubMed ID: 24646664
[TBL] [Abstract][Full Text] [Related]
17. [Ocular paraneoplastic syndrome: cancer-associated retinopathy].
Sampedro A; Carballo C; Barbón JJ; Andrés A; Viña C; Abelairas V
Arch Soc Esp Oftalmol; 2013 Oct; 88(10):407-9. PubMed ID: 24060306
[TBL] [Abstract][Full Text] [Related]
18. Non-Paraneoplastic Autoimmune Retinopathy: The First Case Report in Korea.
Choi EY; Kim M; Adamus G; Koh HJ; Lee SC
Yonsei Med J; 2016 Mar; 57(2):527-31. PubMed ID: 26847311
[TBL] [Abstract][Full Text] [Related]
19. Lack of Correlation between Number of Antiretinal Antibodies and Clinical Outcome Measures in Autoimmune Retinopathy Patients.
Stanwyck LK; Moussa K; Chan W; Aitken PA; Sobrin L
Ophthalmol Retina; 2019 Nov; 3(11):1007-1009. PubMed ID: 31420299
[No Abstract] [Full Text] [Related]
20. Slowly progressive non-neoplastic autoimmune-like retinopathy.
Ohta K; Kikuchi T; Yoshida N
Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):155-8. PubMed ID: 20625760
[No Abstract] [Full Text] [Related]
[Next] [New Search]
